Abstract
The identification of individuals at high risk of developing hypertension can be of great value to improve the efficiency of primary prevention strategies for hypertension. The objective of this study was to develop a risk prediction model for incident hypertension based on prospective longitudinal data from a general Japanese population. A total of 982 subjects aged 40–59 years without hypertension at baseline were followed up for 10 years (2002–12) for the incidence of hypertension. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or the use of antihypertensive agents. The risk prediction model was developed using a Cox proportional hazards model. A simple risk scoring system was also established based on the developed model. During the follow-up period (median 10 years, interquartile range 5–10 years), 302 subjects (120 men and 182 women) developed new-onset hypertension. The risk prediction model for hypertension consisted of age, sex, SBP, DBP, use of glucose-lowering agents, body mass index (BMI), parental history of hypertension, moderate-to-high alcohol intake, and the interaction between age and BMI. The developed model demonstrated good discrimination (Harrell’s C statistic=0.812 [95% confidence interval, 0.791–0.834]; optimism-corrected C statistic based on 200 bootstrap samples=0.804) and calibration (Greenwood-Nam-D’Agostino χ2 statistic=12.2). This risk prediction model is a useful guide for estimating an individual’s absolute risk for hypertension and could facilitate the management of Japanese individuals at high risk of developing hypertension in the future.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. GDB 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–94.
Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386:801–12.
Fukuhara M, Arima H, Ninomiya T, Hata J, Yonemoto K, Doi Y, et al. Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study. J Hypertens. 2012;30:893–900.
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.
Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–93.
Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326.
He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325.
Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OSM, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2:e108–120.
Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2:e004473.
He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. 2000;35:544–9.
Whelton PK, Appel L, Charleston J, Dalcin A, Haythornthwaite J, Rosofsky W, et al. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157:657–67.
Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N. Engl J Med. 2006;354:1685–97.
Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med. 2008;148:102–10.
Paynter NP, Cook NR, Everett BM, Sesso HD, Buring JE, Ridker PM. Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med. 2009;122:464–71.
Kivimaki M, Tabak AG, Batty GD, Ferrie JE, Nabi H, Marmot MG, et al. Incremental predictive value of adding past blood pressure measurements to the Framingham Hypertension Risk Equation: the Whitehall II Study. Hypertension. 2010;55:1058–62.
Kshirsagar AV, Chiu YL, Bomback AS, August PA, Viera AJ, Colindres RE, et al. A hypertension risk score for middle-aged and older adults. J Clin Hypertens. 2010;12:800–8.
Bozorgmanesh M, Hadaegh F, Mehrabi Y, Azizi F. A point-score system superior to blood pressure measures alone for predicting incident hypertension: Tehran Lipid and Glucose Study. J Hypertens. 2011;29:1486–93.
Fava C, Sjögren M, Montagnana M, Danese E, Almgren P, Engström G, et al. Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes. Hypertension. 2013;61:319–26.
Chien KL, Hsu HC, Su TC, Chang WT, Sung FC, Chen MF, et al. Prediction models for the risk of new-onset hypertension in ethnic Chinese in Taiwan. J Hum Hypertens. 2011;25:294–303.
Lim NK, Son KH, Lee KS, Park HY, Cho MC. Predicting the risk of incident hypertension in a Korean middle-aged population: Korean Genome and Epidemiology Study. J Clin Hypertens. 2013;15:344–9.
Chen Y, Wang C, Liu Y, Yuan Z, Zhang W, Li X, et al. Incident hypertension and its prediction model in a prospective northern urban Han Chinese cohort study. J Hum Hypertens. 2016;30:794–800.
Xu F, Zhu J, Sun N, Wang L, Xie C, Tang Q, et al. Development and validation of prediction models for hypertension risks in rural Chinese populations. J Glob Health. 2019;9:020601.
Kanegae H, Oikawa T, Suzuki K, Okawara Y, Kario K. Developing and validating a new precise risk-prediction model for new-onset hypertension: the Jichi Genki hypertension prediction model (JG model). J Clin Hypertens. 2018;20:880–90.
Otsuka T, Kachi Y, Takada H, Kato K, Kodani E, Ibuki C, et al. Development of a risk prediction model for incident hypertension in a working-age Japanese male population. Hypertens Res. 2015;38:419–25.
D’Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180–7.
Ninomiya T. Japanese legacy cohort studies: the Hisayama Study. J Epidemiol. 2018;28:444–51.
Ohmori S, Kiyohara Y, Kato I, Kubo M, Tanizaki Y, Iwamoto H, et al. Alcohol intake and future incidence of hypertension in a general Japanese population: the Hisayama Study. Alcohol Clin Exp Res. 2002;26:1010–6.
Figueiredo D, Azevedo A, Pereira M, de Barros H. Definition of hypertension: the impact of number of visits for blood pressure measurement. Rev Port Cardiol. 2009;28:775–83.
Liu YL, Mi YJ, Zhang B, Wang HJ, Yu J, Pan XB, et al. The impact of hypertension definition based on two-visit strategy on estimate of hypertension burden: results from the China Health and Nutrition Survey 1989-2011. J Epidemiol. 2021;31:180–6.
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.
Kobayashi S, Honda S, Murakami K, Sasaki S, Okubo H, Hirota N, et al. Both comprehensive and brief self-administered diet history questionnaires satisfactorily rank nutrient intakes in Japanese adults. J Epidemiol. 2012;22:151–9.
Resources Council of Science and Technology Agency. Standard tables of food composition in Japan, 4th revision (in Japanese). Tokyo, Japan: Ministry of Finance Printing Bureau, 1982.
Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–28S.
Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109–23.
Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.
Demler OV, Paynter NP, Cook NR. Tests of calibration and goodness-of-fit in the survival setting. Stat Med. 2015;34:1659–80.
D’Agostino RB, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart. 2013;8:11–23.
Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631–60.
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:e13–115.
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;2018:3021–104.
Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. the Framingham Heart Study. Circulation. 1997;96:308–15.
Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, Asmar R, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens. 2002;15:1101–8.
Hisamatsu T, Segawa H, Kadota A, Ohkubo T, Arima H, Miura K. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020;43:1344–51.
Nishi N. Monitoring obesity trends in health Japan 21. J Nutr Sci Vitaminol (Tokyo). 2015;61:S17–S19.
Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular Disease. Nat Rev Nephrol. 2018;14:185–201.
Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis. Clin Chim Acta. 2017;464:57–63.
Hottenga JJ, Boomsma DI, Kupper N, Posthuma D, Snieder H, Willemsen G, et al. Heritability and stability of resting blood pressure. Twin Res Hum Genet. 2005;8:499–508.
Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, et al. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet. 2016;48:1171–84.
Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49:403–15.
Kotsis V, Jordan J, Micic D, Finer N, Leitner DR, Toplak H, et al. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. J Hypertens. 2018;36:1427–40.
Wilson PW, D’Agostino RB, Sullivan L, Parise H, William B, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867–72.
Liu F, Liu Y, Sun X, Yin Z, Li H, Deng K, et al. Race- and sex-specific association between alcohol consumption and hypertension in 22 cohort studies: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020;30:1249–59.
Husain K, Ansari RA, Ferder L. Alcohol-induced hypertension: mechanism and prevention. World J Cardiol. 2014;6:245–52.
Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OSM, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2:e108–120.
Nagahama K, Inoue T, Iseki K, Touma T, Kinjyo K, Ohya Y, et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res. 2004;27:835–41.
Okubo Y, Suwazono Y, Kobayashi E, Nogawa K. An association between smoking habits and blood pressure in normotensive Japanese men: a 5-year follow-up study. Drug Alcohol Depend. 2004;73:167–74.
Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, et al. A longitudinal study of hypertension risk factors and their elation to cardiovascular disease: the Strong Heart Study. Hypertension. 2006;47:403–9.
Bowman TS, Gaziano JM, Buring JE, Sesso HD. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol. 2007;50:2085–92.
Dochi M, Sakata K, Oishi M, Tanaka K, Kobayashi E, Suwazono Y. Smoking as an independent risk factor for hypertension: a 14-year longitudinal study in male Japanese workers. Tohoku J Exp Med. 2009;217:37–43.
Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, et al. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol. 2011;300:H388–396.
Greens MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J. 1986;111:932–40.
Yoon C, Goh E, Park SM, Cho B. Effects of smoking cessation and weight gain on cardiovascular disease risk factors in Asian male population. Atherosclerosis. 2010;208:275–9.
Filozof C, Pinilla MCF, Fernández-Cruz A. Smoking cessation and weight gain. Obes Rev. 2004;5:95–103.
Vasan RS. A risk score for risk factors: rationale and roadmap for preventing hypertension. Hypertension. 2009;54:454–6.
Acknowledgements
The authors thank the residents of the town of Hisayama for their participation in the survey and the staff of the Division of Health of Hisayama for their cooperation with this study. The statistical analyses were carried out using the computer resources offered under the category of General Projects by the Research Institute for Information Technology, Kyushu University.
Funding
This study was supported in part by Grants-in-Aid for Scientific Research A (JP16H02692), B (JP17H04126, JP18H02737, and JP19H03863), and C (JP18K07565, JP18K09412, JP19K07890, JP20K10503, and JP20K11020), and by Grants-in-Aid for Early-Career Scientists (JP18K17925) and Research Activity Start-up (JP19K23971) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by the Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan (20FA1002); and by the Japan Agency for Medical Research and Development (JP20dk0207025, JP20km0405202, and JP20fk0108075).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Oishi, E., Hata, J., Honda, T. et al. Development of a risk prediction model for incident hypertension in Japanese individuals: the Hisayama Study. Hypertens Res 44, 1221–1229 (2021). https://doi.org/10.1038/s41440-021-00673-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-021-00673-7
Keywords
This article is cited by
-
Risk of diabetes and hypertension in a population with alcohol use disorders
BMC Public Health (2024)
-
Development of hypertension models for lung cancer screening cohorts using clinical and thoracic aorta imaging factors
Scientific Reports (2024)